# SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Source: https://onco.cc/trials/nct05775146/  
OnCo record `nct05775146` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by AHS Cancer Control Alberta, now recruiting.

## Summary

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases is a phase 2, interventional study registered as NCT05775146 by AHS Cancer Control Alberta, with a registry enrolment figure of 24 participants, started 2024-06-18 and due to reach its primary completion in 2028-06-30. Interventions recorded: stereotactic body radiation treatment (SBRT). Conditions listed: Colorectal Cancer; Liver Metastasis Colon Cancer. Primary outcome: Progression free survival (PFS). Colorectal eligibility wording from the registry: "* Colon cancer patients who have undergone upfront resection of primary colonic lesion can be included". Sites: Canada. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT05775146
- Phase: 2
- Setting: Phase II Single Arm Feasibility Trial to Evaluate Stereotactic Ablative Radiation of Metastases for the Management of Colorectal Cancer With Synchronous Oligo-metastases in Liver
- Sponsor: AHS Cancer Control Alberta
- Enrolled: 24

## Sources

- ClinicalTrials.gov NCT05775146: https://clinicaltrials.gov/study/NCT05775146

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- technologies: [SBRT / SABR (stereotactic radiotherapy)](https://onco.cc/technologies/sbrt/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05775146.json